Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v7-FR
Language French French
Date Updated 2020-06-10 2017-07-25
Drug Identification Number 02431122 02431122
Brand name PMS-IMATINIB PMS-IMATINIB
Common or Proper name IMATINIB IMATINIB
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients IMATINIB IMATINIB
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code L01XE L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-05-20 2017-05-20
Actual start date 2017-07-30
Estimated end date Unknown Unknown
Actual end date 2020-06-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments No more supplier
Health Canada comments